{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:46:18Z","timestamp":1787755578977,"version":"build-2784847793"},"reference-count":21,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.jns.2008.02.022","type":"journal-article","created":{"date-parts":[[2008,5,16]],"date-time":"2008-05-16T16:36:14Z","timestamp":1210955774000},"page":"34-39","source":"Crossref","is-referenced-by-count":39,"title":["The clinical value of therapeutic plasma exchange in multifocal motor neuropathy"],"prefix":"10.1016","volume":"271","author":[{"given":"Helmar C.","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix R.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Fusshoeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd Meyer","family":"zu H\u00f6rste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Hetzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schroeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd C.","family":"Kieseier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2008.02.022_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(05)70074-0","article-title":"Multifocal motor neuropathy","volume":"4","author":"Van Asseldonk","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2008.02.022_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1085-9489.2006.00058.x","article-title":"Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society","volume":"11","author":"European Federation of Neurological Societies","year":"2006","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jns.2008.02.022_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnen\/63.2.129","article-title":"Multifocal motor neuropathy: pathologic alterations at the site of conduction block","volume":"63","author":"Taylor","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jns.2008.02.022_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(01)00266-1","article-title":"Multifocal motor neuropathy","volume":"115","author":"Nobile-Orazio","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2008.02.022_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/jnnp.2005.064816","article-title":"Axon loss is an important determinant of weakness in multifocal motor neuropathy","volume":"77","author":"van Asseldonk","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2008.02.022_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/brain\/124.1.145","article-title":"Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study","volume":"124","author":"L\u00e9ger","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jns.2008.02.022_bib7","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jns.2008.02.022_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","article-title":"Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"314","author":"Dyck","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2008.02.022_bib9","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM199111213252105","article-title":"Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance","volume":"325","author":"Dyck","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2008.02.022_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.410300312","article-title":"Immunosuppressive treatment in multifocal motor neuropathy","volume":"30","author":"Feldman","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2008.02.022_bib11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/jnnp.68.4.533","article-title":"Plasmapheresis in multifocal motor neuropathy: a case report","volume":"68","author":"Specht","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2008.02.022_bib12","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.50.5.1480","article-title":"Deterioration of multifocal motor neuropathy after plasma exchange","volume":"50","author":"Carpo","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.02.022_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jnnp.72.6.761","article-title":"Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of conduction block","volume":"72","author":"Nobile-Orazio","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2008.02.022_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1468-1331.1999.610071.x","article-title":"Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies","volume":"6","author":"Willison","year":"1999","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2008.02.022_bib15","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archneur.63.8.1066","article-title":"Plasma exchange in neuroimmunological disorders. Part 2 Treatment of neuromuscular disorders","volume":"63","author":"Lehmann","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2008.02.022_bib16","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.50.5.1480","article-title":"Deterioration of multifocal neuropathy after plasma exchange","volume":"50","author":"Carpo","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.02.022_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410240113","article-title":"A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside","volume":"24","author":"Pestronk","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2008.02.022_bib18","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1212\/01.WNL.0000145706.04340.25","article-title":"Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg","volume":"63","author":"Ruegg","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.02.022_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-510X(01)00580-9","article-title":"Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain\u2013Barre syndrome","volume":"190","author":"Press","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2008.02.022_bib20","first-page":"116","article-title":"Axonal degeneration in the Guillain\u2013Barre syndrome and anti-GM1 ganglioside antibodies","volume":"15","author":"Yuki","year":"1992","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2008.02.022_bib21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","article-title":"Animal model of axonal Guillain\u2013Barre syndrome induced by sensitization with GM1 ganglioside","volume":"49","author":"Yuki","year":"2001","journal-title":"Ann Neurol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08001007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08001007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T12:43:20Z","timestamp":1557578600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X08001007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":21,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0022510X08001007"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2008.02.022","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}